RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 45-55
  • Cancer study boosts hopes for Roche's armed antibody

    Cancer study boosts hopes for Roche's armed antibody
    STOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday. Data...
  • Drug companies pay $25 million to Illinois doctors

    Drug companies pay $25 million to Illinois doctors
    At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms. Doctors in the...
  • Asthma drugs may increase attacks in kids: report

    Asthma drugs may increase attacks in kids: report
    NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
  • IUDs almost halve risk of cervical cancer: study

    IUDs almost halve risk of cervical cancer: study
    LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...
  • UK switches to Merck's Gardasil for HPV vaccination

    UK switches to Merck's Gardasil for HPV vaccination
    LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide...
  • Mailbag: Should they sell seashells at store?

    Perhaps instead of fighting over how many merchants in town sell seashells, they should consider not selling them at all ("Fighting over some seashells," Dave Hansen column, June 2). Yes, I know, they are big sellers, and make money for the merchants....
  • Wealthy nations must follow through on disease fight

    Wealthy nations must follow through on disease fight
    In 1980, I moved my family from Maryland to the White Mountain Apache Reservation in Arizona to work on an issue most people are not comfortable talking about — diarrhea. At the time, diarrhea, which is preventable and treatable, was rampantly...
  • State AG sues maker of diabetes drugs for false advertising

    State AG sues maker of diabetes drugs for false advertising
    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...
  • Big pharma: Few new antibiotics in the works

    Big pharma: Few new antibiotics in the works
    Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as the world confronts the crisis of antibiotic resistance, the industry...
  • Ripley's opens Odditorium at Harborplace

    Ripley's Believe It or Not, one of the first of several new tenants opening for the summer tourist season at Harborplace in downtown Baltimore, will open Saturday in the Light Street Pavilion. Ripley Entertainment Inc. said exhibits at the Inner Harbor...
  • GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says

    GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says
    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...